company background image
ALERS logo

Eurobio Scientific Société anonyme ENXTPA:ALERS Stock Report

Last Price

€13.90

Market Cap

€139.6m

7D

0.7%

1Y

-8.6%

Updated

12 Jul, 2024

Data

Company Financials +

Eurobio Scientific Société anonyme

ENXTPA:ALERS Stock Report

Market Cap: €139.6m

ALERS Stock Overview

Engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer.

ALERS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Eurobio Scientific Société anonyme Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Eurobio Scientific Société anonyme
Historical stock prices
Current Share Price€13.90
52 Week High€18.10
52 Week Low€12.20
Beta-0.33
11 Month Change-5.70%
3 Month Change-11.58%
1 Year Change-8.55%
33 Year Change-21.47%
5 Year Change341.27%
Change since IPO-86.04%

Recent News & Updates

Recent updates

Calculating The Intrinsic Value Of Eurobio Scientific Société anonyme (EPA:ALERS)

Jul 29
Calculating The Intrinsic Value Of Eurobio Scientific Société anonyme (EPA:ALERS)

Estimating The Fair Value Of Eurobio Scientific Société anonyme (EPA:ALERS)

Apr 07
Estimating The Fair Value Of Eurobio Scientific Société anonyme (EPA:ALERS)

Is Now The Time To Put Eurobio Scientific Société anonyme (EPA:ALERS) On Your Watchlist?

Mar 08
Is Now The Time To Put Eurobio Scientific Société anonyme (EPA:ALERS) On Your Watchlist?

Calculating The Intrinsic Value Of Eurobio Scientific Société anonyme (EPA:ALERS)

Jan 03
Calculating The Intrinsic Value Of Eurobio Scientific Société anonyme (EPA:ALERS)

Improved Earnings Required Before Eurobio Scientific Société anonyme (EPA:ALERS) Stock's 28% Jump Looks Justified

Dec 13
Improved Earnings Required Before Eurobio Scientific Société anonyme (EPA:ALERS) Stock's 28% Jump Looks Justified

Should You Be Adding Eurobio Scientific Société anonyme (EPA:ALERS) To Your Watchlist Today?

Nov 20
Should You Be Adding Eurobio Scientific Société anonyme (EPA:ALERS) To Your Watchlist Today?

Eurobio Scientific Société anonyme's (EPA:ALERS) Earnings Are Of Questionable Quality

May 12
Eurobio Scientific Société anonyme's (EPA:ALERS) Earnings Are Of Questionable Quality

Shareholder Returns

ALERSFR BiotechsFR Market
7D0.7%0.2%-0.6%
1Y-8.6%-27.2%-1.3%

Return vs Industry: ALERS exceeded the French Biotechs industry which returned -27.2% over the past year.

Return vs Market: ALERS underperformed the French Market which returned -1.3% over the past year.

Price Volatility

Is ALERS's price volatile compared to industry and market?
ALERS volatility
ALERS Average Weekly Movement2.8%
Biotechs Industry Average Movement6.7%
Market Average Movement4.7%
10% most volatile stocks in FR Market9.5%
10% least volatile stocks in FR Market2.6%

Stable Share Price: ALERS has not had significant price volatility in the past 3 months.

Volatility Over Time: ALERS's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997300Denis Fortierwww.eurobio-scientific.com

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune status against tetanus; and EBX molecular biology family, which includes a range of tests for identifying various pathogens responsible for infectious diseases and assessing the magnitude of the infection. The company also develops other diagnostic products using molecular biology.

Eurobio Scientific Société anonyme Fundamentals Summary

How do Eurobio Scientific Société anonyme's earnings and revenue compare to its market cap?
ALERS fundamental statistics
Market cap€139.61m
Earnings (TTM)€4.84m
Revenue (TTM)€130.65m

28.9x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALERS income statement (TTM)
Revenue€130.65m
Cost of Revenue€79.06m
Gross Profit€51.58m
Other Expenses€46.75m
Earnings€4.84m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.48
Gross Margin39.48%
Net Profit Margin3.70%
Debt/Equity Ratio54.0%

How did ALERS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.